RadBio is a biotechnology startup resulting from the interaction among researchers and doctors with the aim of turning scientific knowledge into diagnostic and therapeutic products.

Its goal is to develop new solutions that help solve complex chronic diseases with a high impact on human health, such as cancer, fibrotic and autoimmune diseases.

RadBio was founded by an entrepreneurial team of doctors specializing in clinical studies for new drugs, in collaboration with scientists from CONICET who seek to enhance their knowledge for the development of innovative and effective medical strategies.